Humacyte Investor Relations Material
Latest events
Q4 2024
Humacyte
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Humacyte Inc
Access all reports
Humacyte, Inc. engages in developing, manufacturing and commercializing products for off-the-shelf therapy. The company focuses on solid tumors, benign bone growths, and vascular disease. It also manufactures human tissue for other therapies. The company was founded in 2004 and is headquartered in Durham, North Carolina.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
HUMA
Country
🇺🇸 United States